You'll continue to hear buzz about Avandia (rosiglitazone)

You'll continue to hear buzz about Avandia (rosiglitazone)...due to loosening of prescribing restrictions in the U.S.

This decision is based on some experts saying there's not enough evidence that Avandia increases the risk of heart attacks.

But don't expect to see an increase in Avandia Rxs. Other experts feel Avandia is still risky...and most patients have moved on to pioglitazone or other diabetes meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote